Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analytical Quality Evaluation of the Tox21 Compound Library.
Richard AM, Tao D, LeClair CA, Leister W, Tretyakov KV, White E 5th, Lewis KC, Sefler A, Shinn P, Collins BJ, Nguyen DT, Ye L, Zhao T, Xu T, Williams AJ, Waidyanatha S, Thomas RS, Tice R, Simeonov A, Huang R. Richard AM, et al. Among authors: nguyen dt. Chem Res Toxicol. 2025 Jan 20;38(1):15-41. doi: 10.1021/acs.chemrestox.4c00330. Epub 2024 Dec 31. Chem Res Toxicol. 2025. PMID: 39829241 Review.
Novel CO2 loaded nanoparticle ultrasound-activated contrast agent: A potential urinary catheter-free modality to detect vesicoureteral reflux.
Lavoie C, Nussbaum Z, Syed H, Chun B, Do V, Nguyen D, Surapaneni A, Hamid E, Rayes A, De La Torre D, Ramirez O, Rosales E, Williams TJ, Yen JT, Chang AY. Lavoie C, et al. Among authors: nguyen d. J Pediatr Urol. 2025 Jan 8:S1477-5131(25)00003-8. doi: 10.1016/j.jpurol.2025.01.003. Online ahead of print. J Pediatr Urol. 2025. PMID: 39828470
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.
Okines AFC, Curigliano G, Mizuno N, Oh DY, Rorive A, Soliman H, Takahashi S, Bekaii-Saab T, Burkard ME, Chung KY, Debruyne PR, Fox JR, Gambardella V, Gil-Martin M, Hamilton EP, Monk BJ, Nakamura Y, Nguyen D, O'Malley DM, Olawaiye AB, Pothuri B, Reck M, Sudo K, Sunakawa Y, Van Marcke C, Yu EY, Ramos J, Tan S, Bieda M, Stinchcombe TE, Pohlmann PR. Okines AFC, et al. Among authors: nguyen d. Nat Med. 2025 Jan 17. doi: 10.1038/s41591-024-03462-0. Online ahead of print. Nat Med. 2025. PMID: 39825152
Risk of cardiovascular disease following degarelix versus gonadotropin-releasing hormone agonists in patients with prostate cancer: a systematic review and meta-analysis.
Odat RM, Jain H, Jain J, Alshwayyat S, Alshwayyat M, Yasin JA, Zyoud A, Alkadomi O, Rababah MK, Alfreijat TM, Ahmad NS, Nguyen D, Gole S. Odat RM, et al. Among authors: nguyen d. Urol Oncol. 2025 Jan 15:S1078-1439(24)01058-5. doi: 10.1016/j.urolonc.2024.12.277. Online ahead of print. Urol Oncol. 2025. PMID: 39818461 Review.
8,070 results